Pyelonephritis is a severe bacterial infection of the upper urinary tract, specifically affecting the renal pelvis and parenchyma. While it can affect anyone, pregnant women face a uniquely high vulnerability. During pregnancy, hormonal shifts—particularly elevated progesterone—cause smooth muscle relaxation throughout the body. This leads to profound dilation of the ureters, known as hydroureter, and sluggish urine flow from the kidneys down to the bladder.
Combined with the physical compression of the ureters by the enlarging uterus, especially on the right side due to dextrorotation, this creates urinary stasis. Bacteria like Escherichia coli easily ascend from the lower urinary tract into these stagnant pools of urine, rapidly multiplying and invading the renal tissue. Midwives must recognize that untreated asymptomatic bacteriuria in early pregnancy frequently progresses to acute pyelonephritis if left unchecked.
The overwhelming majority of upper urinary infections begin as ascending infections from the perineum. The short female urethra and its close proximity to the anal opening make it easy for enteric pathogens to colonize the periurethral area.
Once bacteria attach to the bladder mucosa, they ascend against the downward flow of urine through the ureters, ultimately breaching the vesicoureteral junction and establishing an inflammatory nidus within the renal parenchyma.
Unlike simple lower urinary tract infections that manifest mainly with frequency and dysuria, acute pyelonephritis presents as a systemic illness. Midwives must look beyond simple bladder complaints to identify systemic involvement.
Clinical evaluation must include gentle percussion over the costovertebral angle, which reliably elicits severe pain in a patient with pyelonephritis.
Confirming a diagnosis of pyelonephritis requires a combination of urinalysis, microscopy, and blood work. Midwives should understand what these laboratory markers indicate.
| Test | Expected Finding in Pyelonephritis | Clinical Significance |
|---|---|---|
| Urinalysis | Positive for leukocyte esterase and nitrites | Indicates active white blood cells and bacterial presence |
| Urine Microscopy | Pyuria and white blood cell casts | WBC casts prove the infection originates in the kidney parenchyma |
| Urine Culture | Colony count greater than 10^5 CFU/mL | Identifies the specific organism and guides targeted therapy |
| Full Blood Count | Marked leukocytosis with a left shift | Demonstrates the body's acute systemic inflammatory response |
Blood cultures are also indicated for pregnant or acutely toxic patients to rule out bacteremia and systemic sepsis.
Acute pyelonephritis during pregnancy is treated as a medical emergency requiring prompt hospital admission, aggressive hydration, and intravenous antibiotics. Oral outpatient management is rarely appropriate initially for pregnant women due to the high risk of rapid maternal deterioration and preterm labor.
Initial empirical intravenous therapy typically includes broad-spectrum cephalosporins, such as ceftriaxone, or aminopenicillins combined with beta-lactamase inhibitors, pending sensitivity results. Once the patient has been afebrile and clinically stable for 48 hours, therapy can transition to oral formulations to complete a full 10-to-14-day course. Midwives must monitor vital signs, fluid balance, and urine output rigorously, ensuring that treatment is never stopped prematurely even after symptoms subside.
If acute pyelonephritis is inadequately managed, it poses grave risks to both mother and fetus. The severe systemic inflammatory response releases cytokines and prostaglandins that can stimulate uterine contractions, leading to preterm premature rupture of membranes and preterm labor.
Maternal complications include septic shock, transient renal failure, acute respiratory distress syndrome, and hematologic abnormalities such as disseminated intravascular coagulation. Fetal risks stem directly from maternal high fevers, systemic toxins, and hypoxemia, which can cause intrauterine growth restriction, fetal distress, or fetal demise. Early recognition and aggressive treatment remain the single best defense against these devastating outcomes.
Midwives play a vital role in preventing pyelonephritis through routine antenatal screening and health education. At every antenatal booking visit, urine must be tested for asymptomatic bacteriuria using reagent strips or laboratory culture. Prompt treatment of positive results stops bacteria from ascending to the kidneys.
Education should focus on proper hydration, encouraging pregnant women to drink adequate water daily to flush the urinary tract. Midwives must advise patients never to hold urine when they feel the urge to void, as urinary stasis fosters bacterial growth. Emphasizing proper perineal hygiene—wiping from front to back after elimination—further reduces the transfer of enteric pathogens into the urethra.